Identification of domains within Pfs230 that elicit transmission blocking antibody responses-Reference-Cited by-同舟云学术

Identification of domains within Pfs230 that elicit transmission blocking antibody responses

Published:2019-03 Issue:13 Volume:37 Page:1799-1806
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Tachibana Mayumi,Miura Kazutoyo^ORCID,Takashima Eizo^ORCID,Morita Masayuki,Nagaoka Hikaru,Zhou Luwen,Long Carole A.,Richter King C.,Torii Motomi,Tsuboi Takafumi,Ishino Tomoko^ORCID

Funder

JSPS KAKENHI

NIAID

NIH

PATH’s Malaria Vaccine Initiative

Bill & Melinda Gates Foundation

Global Health Innovative Technology Fund

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference26 articles.

1. WHO. World malaria report; 2017. [accessed 31 Jul 2018].

2. Development of malaria transmission-blocking vaccines: from concept to product;Wu;Adv Parasitol,2015

3. Toward the development of effective transmission-blocking vaccines for malaria;Nikolaeva;Exp Rev Vacc,2015

4. Adhesion protein complexes of malaria gametocytes assemble following parasite transmission to the mosquito;Simon;Parasitol Int,2016

5. Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production;Eksi;Mol Microbiol,2006

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IgM plays a prominent role in naturally acquired immunity againstPlasmodium falciparumgametocytes;2024-07-02

2. Immune mechanisms targeting malaria transmission: opportunities for vaccine development;Expert Review of Vaccines;2024-06-25

3. Vaccines and monoclonal antibodies: new tools for malaria control;Clinical Microbiology Reviews;2024-06-13

4. A Self-Assembling Pfs230D1-Ferritin Nanoparticle Vaccine Has Potent and Durable Malaria Transmission-Reducing Activity;Vaccines;2024-05-16

5. Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody;npj Vaccines;2023-12-12